Ankrin Therapeutics ApS — Credit Rating and Financial Key Figures

Ankrin Therapeutics ApS (CVR number: 39788705) is a company from FREDERIKSBERG. The company recorded a gross profit of -498 kDKK in 2023. The operating profit was -2092.2 kDKK, while net earnings were -2334.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -25.4 %, which can be considered poor and Return on Equity (ROE) was -88.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -80.8 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Ankrin Therapeutics ApS's liquidity measured by quick ratio was 5.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.